Objective: To elucidate the effect and effective mechanism of gonadotropin-releasing hormone analog (GnRHa) on growth axis and gonadal axis in puberty rats.
Methods: After injecting GnRHa on puberty rats, hypothalamus, pituitary, ovary and epiphyseal cartilage of legs were taken, and related gene expression was detected by fluorescence quantitative PCR (FQ-PCR).
Results: GnRHa could reduce the gene expression of gonadotropin-releasing hormone (GnRH) in hypothalamus and its receptor (GnRHR) in pituitary, increase the gene expression of growth hormone releasing inhibiting hormone (SRIH), and not affect the gene expression of growth hormone releasing hormone (GHRH) in hypothalamus. And GnRHa could reduce the gene expression of growth hormone (GH) in pituitary, estrogen receptor (ER) in ovary and insulin-like growth factors-I (IGF-1) in epiphyseal cartilage of legs.
Conclusion: Besides restraining the gene expression of GnRHR in pituitary and leading to descent regulation of receptor, GnRHa can reduce the gene expression of GnRH in hypothalamus and down-regulate gonadal hormone level. At last, GnRHa can reduce the maturity degree and pace of the second sexual characteristics. By means of increasing the gene expression of SRIH in hypothalamus, GnRHa can reduce the gene expression of GH in pituitary and IGF-1 in epiphyseal cartilage of legs. It could be one of the mechanisms of GnRHa reducing epiphyseal maturity for the patients with idiopathic central precocious puberty.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3736/jcim20030115 | DOI Listing |
Lab Anim Res
January 2025
Anatomy Department, Faculty of Basic Medical Sciences, Alex Ekwueme, Federal University, Ndufu-Alike, Ebonyi State, Nigeria.
Background: The Microtubules-associated protein tau (MAPT), alpha-synuclein (SNCA), and leucine zipper tumor suppressor 3 (LZTS3) genes are implicated in neurodegeneration and tumor suppression, respectively. This study investigated the regulatory roles of eugenol on paraquat-altered genes.
Results: Forty male Wistar rats divided into five groups of eight rats were used.
Alzheimers Res Ther
January 2025
Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, Turin, 10126, Italy.
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder with both genetic and environmental factors contributing to its pathogenesis. While early-onset AD has well-established genetic determinants, the genetic basis for late-onset AD remains less clear. This study investigates a large Italian family with late-onset autosomal dominant AD, identifying a novel rare missense variant in GRIN2C gene associated with the disease, and evaluates the functional impact of this variant.
View Article and Find Full Text PDFGenome Med
January 2025
Blizard Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK.
Background: Senescence classification is an acknowledged challenge within the field, as markers are cell-type and context dependent. Currently, multiple morphological and immunofluorescence markers are required. However, emerging scRNA-seq datasets have enabled an increased understanding of senescent cell heterogeneity.
View Article and Find Full Text PDFEpigenetics Chromatin
January 2025
Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.
Background: Colorectal cancer (CRC) remains one of the most common causes of cancer-related mortality worldwide. Its progression is influenced by complex interactions involving genetic, epigenetic, and environmental factors. Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), have been identified as key regulators of gene expression, affecting diverse biological processes, notably programmed cell death (PCD).
View Article and Find Full Text PDFBMC Med Genomics
January 2025
Department of Oncology, The First People's Hospital of Yibin, No.65, Wenxing Street, Cuiping District, Yibin, 644000, China.
Background: Advanced gastric cancer (GC) exhibits a high recurrence rate and a dismal prognosis. Myocyte enhancer factor 2c (MEF2C) was found to contribute to the development of various types of cancer. Therefore, our aim is to develop a prognostic model that predicts the prognosis of GC patients and initially explore the role of MEF2C in immunotherapy for GC.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!